From the blog

Marijuana Is (Partly) Schedule III Now: What Actually Changes for Dispensary Operations? [2026]

July 16, 2026

The DEA's hearing on moving all marijuana to Schedule III wrapped up on July 15 — but if you run a state-licensed medical dispensary, the change that matters to your P&L already happened in April. State-licensed medical cannabis has been Schedule III since April 28, 2026, and the biggest practical effect is a tax one: 280E no longer applies to that business.

Here's what's actually law today, what's still being decided, and what an operator should do about each — without the hype in either direction.

What changed in April (this part is done)

On April 23, the DOJ issued a final order moving two things from Schedule I to Schedule III, effective April 28: marijuana in FDA-approved drug products, and marijuana sold under a state medical license. Everything else — adult-use, unlicensed product — stayed Schedule I.

For a Florida MMTC, that scope is the whole point. Florida is a medical-only state, so the entire licensed business falls on the Schedule III side of the line. The order also met operators partway on mechanics: state medical certifications count (no federal-style prescriptions required), and operators can largely rely on state rules for labeling, packaging, and security rather than a separate federal rulebook.

The catch: Schedule III is a regulated schedule, not a deregulated one. State licensees are expected to hold a DEA registration — dispensaries applied through a dedicated portal with a $794 fee, and the expedited registration window closed in late June. If your registration isn't squared away, that's action item #1, because the DEA has already begun on-site inspections of applicants.

The money: what 280E relief is actually worth

Section 280E barred businesses trafficking in Schedule I or II substances from taking ordinary deductions — rent, payroll, marketing, technology — leaving dispensaries taxed on gross margin instead of profit. Schedule III ends that for state-licensed medical activity, and Treasury's announcement says the relief generally applies to the full taxable year that includes April 28, 2026 — for calendar-year businesses, all of 2026.

Formal IRS guidance is still pending (pending enough that seven House members have publicly demanded it), so don't book anything without your CPA. But the direction is clear, and it's why Curaleaf's CEO called out tax relief and capital access as the headline effects — and why Florida's own Trulieve just became the first cannabis company listed on the NYSE. For a single-store operator, deducting normal operating expenses for all of 2026 is real money: the question stops being "can we afford to invest in the store?" and becomes "what do we invest in first?"

What the July hearing was about (this part is pending)

The June 29–July 15 hearing before the DEA's chief administrative law judge considered the broader question: whether all marijuana moves to Schedule III. The moment everyone will remember came under cross-examination, when the opposition's own expert — a Harvard professor testifying for Smart Approaches to Marijuana — acknowledged that cannabis meets the statutory criteria for Schedule III.

What happens next is paperwork, not drama: parties file post-hearing briefs, the judge issues a recommended decision, and the DEA Administrator makes the final call — appealable to federal court, with three consolidated challenges to the April order already sitting in the D.C. Circuit. Realistic timeline: optimists say a final rule within a year; history says these proceedings can run much longer. Plan your business on what's already law, not on the next ruling.

What doesn't change (and what your patients will ask)

Rescheduling is not legalization. Interstate commerce is still off the table, your state's rules still govern what you can sell and what you can display in-store, employers can still drug-test, and nothing moved for adult-use. Florida's governor shrugged the whole thing off with "it is what it is." Your compliance obligations on the sales floor today look almost exactly like they did in March.

But your patients read the same headlines you do. With nearly 935,000 active patients in Florida and more walking in every week, "is weed federally legal now?" is a question your budtenders will field daily. A short, accurate answer — medical is Schedule III, your card still matters, nothing changed about how you buy — is exactly the kind of education that belongs on a lobby screen, where it saves the counter conversation for selling.

The operator to-do list

1. Sit down with your CPA this quarter. The 280E change applies to all of 2026 for most operators — estimated payments, entity structure, and prior-year positions are all worth revisiting while formal IRS guidance is still landing.

2. Confirm your DEA registration status. The expedited window closed in June and inspections have started. This is now basic hygiene, like your state license renewal.

3. Put the windfall where patients can see it. The operators who win the next two years will reinvest the 280E savings in the store — staffing, experience, and the screens and menus that do the selling. Your competitors just got the same tax cut; the difference will be who spends it visibly.

4. Keep your in-store messaging compliant and current. Rescheduling changed Washington, not your state's display rules — and a menu that updates itself is the easiest way to stay accurate while the rules keep moving.

That last part is what we build. GreenScreens keeps every screen synced to your POS and your education loops current across every location — so when the rules change again (and they will), updating your stores takes minutes, not a truck roll. See how it works or book a demo.

This article is general information for dispensary operators, not legal or tax advice. The rescheduling process is active — the ALJ's recommendation, IRS guidance, and pending D.C. Circuit challenges could all change the picture. Confirm current requirements with your counsel and CPA before acting.